Oslo Pensjonsforsikring AS Buys Shares of 1,964 Cigna Group $CI

Oslo Pensjonsforsikring AS bought a new position in Cigna Group (NYSE:CIFree Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 1,964 shares of the health services provider’s stock, valued at approximately $524,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group in the 4th quarter valued at approximately $25,000. Beacon Financial Strategies CORP bought a new position in Cigna Group during the fourth quarter valued at approximately $28,000. Cedar Mountain Advisors LLC lifted its stake in Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the last quarter. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group in the fourth quarter valued at approximately $29,000. Finally, Prosperity Bancshares Inc bought a new stake in Cigna Group in the fourth quarter worth approximately $29,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CI has been the topic of several analyst reports. Jefferies Financial Group dropped their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research note on Monday, April 20th. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $303.00 to $302.00 in a report on Wednesday, May 20th. Sanford C. Bernstein increased their target price on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Morgan Stanley raised their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Finally, The Goldman Sachs Group boosted their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and an average price target of $338.80.

Read Our Latest Analysis on CI

Cigna Group Price Performance

NYSE CI opened at $289.82 on Wednesday. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The company has a fifty day simple moving average of $286.41 and a 200 day simple moving average of $280.59. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a market cap of $76.67 billion, a P/E ratio of 12.29, a P/E/G ratio of 1.09 and a beta of 0.29.

Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same quarter last year, the firm posted $6.74 EPS. The business’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts predict that Cigna Group will post 30.39 EPS for the current year.

Insider Activity

In other news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by corporate insiders.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.